Paris, France, November 22nd 2024 – Jeito is pleased to announce that Dr Rafaèle Tordjman has received L’Agefi’s prestigious 2024 ‘AM Leader’ Award at L’Agefi’s annual “Grands Prix” ceremony. The award recognizes outstanding leadership in the asset management industry, celebrating exceptional achievements, commitment, and contributions to advancing the field.
Her unique path began as a doctor, physician and researcher in haemato-oncology at Hôpitaux de Paris and INSERM, before transitioning to life sciences investment, where she has now been a leading figure for over 20 years.
In 2021, she founded Jeito Capital, a global leading independent Private Equity fund dedicated to biopharma, that finances and accelerates the development of ground-breaking medical innovation for the benefit of patients.
Upon receiving the award, Dr Tordjman said: “In a world where two-thirds of diseases still lack effective treatments, Jeito is committed to accelerating groundbreaking medical innovations that transform patients’ lives. This recognition belongs to our entire team of exceptional professionals who make our mission possible. While investment requires expertise, methodology and discipline, it’s increasingly driven by conviction and purpose. This award validates our commitment and achievements. It encourages us to pursue our vision of developing revolutionary treatments for tomorrow.”